Active Share (vs S&P 500): 91.2%
· vs QQQ: 92.5%
— share of the book that differs from index weights (higher = more active)
· ranking
In its Q3 2026 13F filing, Farallon Capital Management disclosed 109 equity positions with a combined reported value of $22.58B. The filing implies a focused portfolio: its ten largest positions account for 62.3% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B). By sector, the heaviest allocations are Health Care 51.5%, Communication Services 9.6%. Versus the prior quarter, allocation shifted toward Communication Services (+9.6pp), Consumer Discretionary (+2.0pp) and away from Financials (-0.5pp), Other (-12.4pp).
Versus the prior quarter, Farallon Capital Management opened 43 new positions, trimmed 19 and fully exited 22, a turnover rate of 64.1% of positions. The portfolio's overlap with the prior quarter was 49% of names.
The largest new positions opened in Q3 2026 were ROKU ($633.49M), CRH ($442.24M), IONI ($57.69M).
Of the 22 positions fully exited versus the prior quarter, the largest were EA ($1.62B), CRNX ($336.37M), NVO ($125.55M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
PCSCPERCEPTIVE CAP SOLUTIONS COR · prev qtr: $24.48M
Insider Transactions (Form 4)
Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Farallon Capital Management files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 109 positions worth $22.58B in total. HoldingsHub carries 21 quarters of its filings (Q3 2021–Q3 2026).
Portfolio Structure
109 positions · $22.58B reported value (Q3 2026)
Top 10 holdings = 62.3% of reported value
Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 17.6%
Average position size: $207.17M
Sector Tilt
Health Care 51.5%
Communication Services 9.6%
Information Technology 6.8%
(classified holdings cover 82% of value)
Quarterly Activity
Q3 2026: 43 new, 23 added, 19 reduced, 22 exited
24 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure to large-cap passive (SPY) and mega-cap tech (AMZN), while adding high-growth healthcare and communication services stocks, indicating a tilt toward active management, growth sectors, and potential rotation away from passive index exposure.
2. Key moves:
- Reduced: SPY (by 13.0% shares), AMZN (by 10.0% shares), RVMD (by 1.0% shares).
- Added: WBD (new, +75.7% shares), NTRA (+17.2% shares), BBIO (+32.6% shares), PTGX (+1.4% shares), EXEL (+9.1% shares), ROIV (+52.0% shares), ROKU (new).
3. Portfolio structure: Active, with heavy bias toward Health Care (6/10 top holdings) and Communication Services (2/10), high risk appetite (concentrated positions, volatile biotech names), and reduced passive index exposure.
4. Per-holding one-liner:
- SPY: S&P 500 ETF (benchmark).
- RVMD: Unverified (Revolution Medicines—likely biotech).
- WBD: Warner Bros (media/entertainment).
- NTRA: Natera (genetic testing).
- BBIO: BridgeBio Pharma (biotech).
- PTGX: Protagonist Therapeutics (biotech).
- EXEL: Exelixis (oncology).
- ROIV: Roivant Sciences (biotech).
- ROKU: Roku (streaming).
- AMZN: Amazon (e-commerce/cloud).
5. Style summary: Rotated from passive large-cap to active healthcare/communication growth bets, increasing risk and sector concentration.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-22 09:14
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 70%R 70%F1 70%(modelled on 2026-Q2; 7/10 hit)
Low-confidence forecast
This fund replaces about 32% of its Top-10 each quarter and
backtests at F1 68% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
SPY · RVMD · WBD · NTRA · BBIO · PTGX · EXEL · ROIV · ROKU · AMZN
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q2 13F is held at its
report-date weights and decomposed over 2026-06-30 ~ 2026-09-30.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+4.40%
Disclosed long book
QQQ synthetic benchmark
+3.82%
Liquidity-weighted constituents
Model universe, equal weight
-2.35%
Opportunity-cost reference
Excess return
+0.59%
Portfolio − benchmark
Arithmetic return sum
+4.64%
Difference vs compounded is the cross term
Weighted raw beta
1.01
Weighted holding betas
Realised volatility (annualised)
16.14%
Daily returns in window
Barra model volatility (annualised)
27.06%
Factor + specific
Factor share of variance
80.7%
Barra factors
Specific share of variance
19.3%
Stock residuals
Reported value
$17.89B
13F long US equity
2. Return attribution
The +4.64% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
+4.08%
88.1%
Momentum & Growth
3
+0.19%
4.1%
Volatility & Tail Risk
7
-4.35%
-93.8%
Industry
12
+3.13%
67.4%
Specific
1
+1.59%
34.2%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Non-linear Size
Style
+1.91
+2.34%
+4.46%
96.3%
Health Care
Industry
+0.56
+7.53%
+4.21%
90.7%
Momentum
Style
+0.65
+2.52%
+1.65%
35.6%
Specific
Specific
—
—
+1.59%
34.2%
Skewness
Style
+0.48
+1.53%
+0.73%
15.8%
Information Technology
Industry
+0.08
+6.79%
+0.53%
11.4%
Mid Cap
Style
+0.42
+0.53%
+0.22%
4.7%
Leverage (Downside Vol)
Style
-0.34
-0.49%
+0.17%
3.6%
Growth
Style
+0.29
+0.49%
+0.14%
3.1%
Liquidity
Style
+0.03
-2.77%
-0.09%
-2.0%
Consumer Discretionary
Industry
+0.04
-4.50%
-0.16%
-3.4%
Historical Volatility
Style
+0.27
-1.03%
-0.28%
-6.0%
Industrials
Industry
+0.03
-10.14%
-0.31%
-6.6%
Beta
Style
+0.16
-1.99%
-0.33%
-7.0%
Size
Style
+0.33
-1.32%
-0.44%
-9.4%
Residual Volatility
Style
+0.19
-3.98%
-0.76%
-16.3%
Other
Industry
+0.25
-4.69%
-1.18%
-25.4%
Kurtosis
Style
+0.73
-1.72%
-1.26%
-27.3%
Short-term Reversal
Style
-0.40
+3.97%
-1.61%
-34.6%
Max Drawdown
Style
+0.44
-5.90%
-2.62%
-56.6%
3. Risk attribution
Annualised volatility is 27.06%; factor risk explains 80.7% of variance and specific risk 19.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Health Care
Industry
+0.56
22.9%
+6.21%
6.2%
Specific
Specific
—
19.4%
+5.24%
5.2%
Non-linear Size
Style
+1.91
19.1%
+5.17%
5.2%
Other
Industry
+0.25
14.5%
+3.92%
3.9%
Mid Cap
Style
+0.42
4.5%
+1.23%
1.2%
Momentum
Style
+0.65
4.1%
+1.10%
1.1%
Beta
Style
+0.16
3.5%
+0.95%
0.9%
Historical Volatility
Style
+0.27
2.9%
+0.79%
0.8%
Information Technology
Industry
+0.08
2.6%
+0.70%
0.7%
Financials
Industry
+0.05
1.5%
+0.41%
0.4%
Consumer Discretionary
Industry
+0.04
1.3%
+0.34%
0.3%
Kurtosis
Style
+0.73
1.1%
+0.30%
0.3%
Max Drawdown
Style
+0.44
1.1%
+0.29%
0.3%
Industrials
Industry
+0.03
1.1%
+0.29%
0.3%
Growth
Style
+0.29
0.9%
+0.23%
0.2%
Leverage (Downside Vol)
Style
-0.34
0.8%
+0.21%
0.2%
Residual Volatility
Style
+0.19
0.6%
+0.17%
0.2%
Amihud Illiquidity
Style
+0.03
-0.4%
-0.12%
-0.1%
Size
Style
+0.33
-0.9%
-0.26%
-0.3%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
+0.33
+2.04
-1.71
Non-linear Size
+1.91
+1.75
+0.16
Mid Cap
+0.42
+0.25
+0.16
Beta
+0.16
+1.20
-1.03
Momentum
+0.66
+0.85
-0.19
Short-term Reversal
-0.40
+0.47
-0.87
Residual Volatility
+0.19
-0.50
+0.69
Historical Volatility
+0.27
+0.74
-0.47
Liquidity
+0.03
-0.01
+0.04
Amihud Illiquidity
+0.03
+0.30
-0.27
Turnover
-0.18
+0.02
-0.20
Growth
+0.29
+0.11
+0.18
Leverage (Downside Vol)
-0.34
-0.36
+0.03
Skewness
+0.48
-0.13
+0.61
Kurtosis
+0.73
-0.13
+0.86
Max Drawdown
+0.45
+0.28
+0.16
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Health Care
55.9%
1.8%
+6.84%
+9.32%
+2.43%
-0.04%
-1.34%
+3.66%
Industrials
3.0%
14.4%
+34.44%
-13.94%
+2.14%
+6.98%
-5.52%
+3.05%
Other
25.0%
0.0%
+2.17%
+0.00%
-1.21%
+0.00%
+0.54%
+0.54%
Consumer Discretionary
3.5%
9.8%
+4.23%
+0.07%
+0.30%
+0.41%
-0.26%
+0.14%
Consumer Staples
0.0%
1.0%
+0.00%
-12.64%
+0.17%
+0.12%
-0.12%
+0.12%
Utilities
0.0%
0.9%
+0.00%
-4.67%
+0.08%
+0.04%
-0.04%
+0.04%
Communication Services
0.0%
2.6%
+0.00%
+2.28%
+0.07%
-0.06%
+0.06%
-0.06%
Financials
4.7%
0.0%
-9.23%
+0.00%
-0.23%
-0.00%
-0.43%
-0.43%
Information Technology
7.8%
69.0%
+5.43%
+6.14%
-0.80%
-0.49%
+0.43%
-3.81%
Total
+2.99%
+6.98%
-6.69%
+3.27%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
SPY
STATE STREET
Other
25.05%
+2.17%
+0.55%
New
RVMD
REVOLUTION MEDICINES INC COM
Health Care
14.19%
+9.60%
+1.36%
Hold
BBIO
BRIDGEBIO PHARMA INC
Health Care
4.47%
-11.65%
-0.52%
Add
PTGX
PROTAGONIST THERAPEUTICS INC
Health Care
4.35%
+14.94%
+0.65%
Hold
EXEL
EXELIXIS INC
Health Care
4.10%
+6.30%
+0.26%
Add
LQDA
LIQUIDIA CORP
Health Care
3.73%
-62.05%
-2.31%
Reduce
AMZN
AMAZON COM INC
Consumer Discretionary
3.51%
+4.23%
+0.15%
Reduce
LNTH
LANTHEUS HOLDINGS INC
Health Care
3.46%
-10.29%
-0.36%
Hold
NTRA
NATERA INC
Health Care
3.37%
+101.63%
+3.42%
Reduce
UNH
Unitedhealth Group Inc
Health Care
2.95%
-11.61%
-0.34%
Reduce
TMO
THERMO FISHER
Industrials
2.94%
+34.64%
+1.02%
Add
ROIV
ROIVANT SCIENCES LTD F
Health Care
2.83%
+3.33%
+0.09%
Add
AON
AON PLC SHS CL A
Financials
2.56%
-16.56%
-0.42%
Reduce
BSX
BOSTON SCIENTIFIC CORP COM
Health Care
2.51%
+2.27%
+0.06%
Add
AVGO
BROADCOM INC
Information Technology
2.43%
-6.96%
-0.17%
Reduce
MSFT
MICROSOFT CORP
Information Technology
2.32%
+36.55%
+0.85%
Reduce
TNGX
TANGO THERAPEUTICS INC
Health Care
2.15%
-20.19%
-0.43%
Add
KKR
KKR & CO INC COM
Financials
2.11%
-0.33%
-0.01%
Reduce
SNPS
SYNOPSYS INC COM
Information Technology
2.07%
-2.35%
-0.05%
Reduce
BEAM
BEAM THERAPEUTICS INC COM
Health Care
1.96%
-31.89%
-0.63%
Add
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
NTRA
Health Care
3.37%
+101.63%
+3.42%
2
GRAL
Health Care
1.59%
+105.24%
+1.67%
3
RVMD
Health Care
14.19%
+9.60%
+1.36%
4
TWST
Health Care
1.23%
+87.83%
+1.08%
5
TMO
Industrials
2.94%
+34.64%
+1.02%
6
MSFT
Information Technology
2.32%
+36.55%
+0.85%
7
PTGX
Health Care
4.35%
+14.94%
+0.65%
8
SPY
Other
25.05%
+2.17%
+0.55%
9
AON
Financials
2.56%
-16.56%
-0.42%
10
TNGX
Health Care
2.15%
-20.19%
-0.43%
11
BBIO
Health Care
4.47%
-11.65%
-0.52%
12
BEAM
Health Care
1.96%
-31.89%
-0.63%
13
LQDA
Health Care
3.73%
-62.05%
-2.31%
7. Conclusions
Over the attribution window 2026-06-30 → 2026-09-30 (64 trading days), the reported portfolio returned +4.40%, versus +3.82% for the QQQ synthetic benchmark — an excess of +0.59%.
Return attribution: the largest positive style/industry contributions came from Non-linear Size +4.46%, Health Care +4.21%, Momentum +1.65%; the largest drags came from Max Drawdown -2.62%, Short-term Reversal -1.61%, Kurtosis -1.26%. Specific (stock-level) return contributed +1.59%.
Risk attribution: Barra model volatility is 27.06% annualised; factor risk explains 81% of variance and specific risk 19%. The largest factor risk sources are Health Care 22.9%, Non-linear Size 19.1%, Other 14.5%.
Style tilt: size +0.33, momentum +0.66, volatility +0.27, liquidity +0.03; the weighted raw beta is 1.01. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+54.1 pp), the largest underweight is Information Technology (-61.2 pp). Allocation contributed +2.99%, selection +6.98% and interaction -6.69%.
Concentration: the top-10 positions are 69.2% of the attributed portfolio and the model covers 99.9% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Farallon Capital Management buy in 2026-Q3?
In its 2026-Q3 13F filing, Farallon Capital Management reported 109 equity positions worth $22.58B in aggregate; its largest disclosed positions were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B).
How large is Farallon Capital Management's portfolio?
Farallon Capital Management reported $22.58B of long equity holdings across 109 positions as of 2026-Q3. Top-10 holdings account for 62.3% of reported value.
What is Farallon Capital Management's investment style?
HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/farallon/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>